(Q48286498)

10 February 2018

title

Deficits in iodine-labelled 3-quinuclidinyl benzilate binding in relation to cerebral blood flow in patients with Alzheimer's disease. (English)

1 reference

10 February 2018

0 references

0 references

D J Wyper

1

1 reference

10 February 2018

D Brown

2

1 reference

10 February 2018

J Patterson

3

1 reference

10 February 2018

J Owens

4

1 reference

10 February 2018

R Hunter

5

1 reference

10 February 2018

E Teasdale

6

1 reference

10 February 2018

J McCulloch

7

1 reference

10 February 2018

publication date

1 May 1993

1 reference

10 February 2018

number of pages

8

1 reference

European Journal of Nuclear Medicine and Molecular Imaging

inferred from page(s)

published in

1 reference

10 February 2018

volume

20

1 reference

10 February 2018

page(s)

379-386

1 reference

10 February 2018

issue

5

1 reference

10 February 2018

https://scigraph.springernature.com/pub.10.1007/bf00208995

exact match

0 references

cites work

CAMDEX. A standardised instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia.

1 reference

12 December 2020

Technetium-99m d,l-HM-PAO: a new radiopharmaceutical for SPECT imaging of regional cerebral blood perfusion

1 reference

12 December 2020

Muscarinic acetylcholine receptors in Alzheimer's disease. In vivo imaging with iodine 123-labeled 3-quinuclidinyl-4-iodobenzilate and emission tomography.

1 reference

12 December 2020

Cholinergic receptor binding and autoradiography in brains of non-neurological and senile dementia of Alzheimer-type patients.

1 reference

12 December 2020

A comparison of FDG PET and IQNB SPECT in normal subjects and in patients with dementia

1 reference

12 December 2020

[125I] 3-quinuclidinyl 4-iodobenzilate: a high affinity, high specific activity radioligand for the M1 and M2-acetylcholine receptors

1 reference

12 December 2020

Muscarinic and nicotinic cholinergic binding sites in Alzheimer's disease cerebral cortex.

1 reference

12 December 2020

Laminar organization of cholinergic circuits in human frontal cortex in Alzheimer's disease and aging.

1 reference

12 December 2020

Regional distribution of muscarinic acetylcholine receptor in normal and Alzheimer's-type dementia brains

1 reference

12 December 2020

Muscarinic cholinergic receptor subtypes in hippocampus in human cognitive disorders.

1 reference

12 December 2020

Cholinergic topography in Alzheimer brains: a comparison with changes in the monoaminergic profile

1 reference

12 December 2020

Changes in nicotinic and muscarinic cholinergic receptors in Alzheimer-type dementia.

1 reference

12 December 2020

1 reference

12 December 2020

Alzheimer's disease: choline acetyltransferase activity in brain tissue from clinical and pathological subgroups

1 reference

12 December 2020

Glucose metabolism and acetylcholine synthesis in relation to neuronal activity in Alzheimer's disease.

1 reference

12 December 2020

Differential modification of muscarinic cholinergic receptors in the hippocampus of patients with Alzheimer's disease: an autoradiographic study.

1 reference

12 December 2020

Brain muscarinic receptors in senile dementia.

1 reference

12 December 2020

The distribution of cerebral muscarinic acetylcholine receptors in vivo in patients with dementia. A controlled study with 123IQNB and single photon emission computed tomography.

1 reference

12 December 2020

Muscarinic binding and choline acetyltransferase in postmortem brains of demented patients.

1 reference

12 December 2020

Biochemical Assessment of Serotonergic and Cholinergic Dysfunction and Cerebral Atrophy in Alzheimer's Disease

1 reference

12 December 2020

Cortical muscarinic receptor subtypes and Alzheimer's disease

1 reference

12 December 2020

A post-mortem study of the cholinergic and GABA systems in senile dementia.

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00208995

1 reference

10 February 2018

PubMed ID

8519256

1 reference

10 February 2018